Paper268229
Prolonged remission maintenance in acute myeloid leukaemia.
Spiers AS and 5 others. Br Med J, 1977. Cited by 37 papers, by iCite.
Cite this record
ConductScience Library. Prolonged remission maintenance in acute myeloid leukaemia. Papers, record 268229. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/268229
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Leukemia, Myeloid, Acute | Major topic |
| Adolescent | |
| Adult | |
| Aged | |
| Child | |
| Child, Preschool | |
| Cyclophosphamide | |
| Cytarabine | |
| Daunorubicin | |
| Drug Therapy, Combination | |
| Female | |
| Humans | |
| Male | |
| Mercaptopurine | |
| Methotrexate | |
| Middle Aged | |
| Prednisolone | |
| Remission, Spontaneous | |
| Thioguanine | |
| Vincristine |
Source PubMed
References15
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 322689 | Immunotherapy for acute myelogenous leukaemia: a controlled clinical study 2 1/2 years after entry of the last patient. | Br J Cancer | 1977 | https://conductscience.org/library/papers/322689 | PubMed |
| 2 | 5100389 | Drug dosage and remission duration in childhood lymphocytic leukemia. | Cancer | 1971 | https://conductscience.org/library/papers/5100389 | PubMed |
| 3 | 984987 | Adult acute leukemia. The Rochester (NY) Experience. | Arch Intern Med | 1976 | https://conductscience.org/library/papers/984987 | PubMed |
| 4 | 4140327 | Chemoimmunotherapy of adult acute leukaemia. Prolongation of remission in myeloblastic leukaemia with B.C.G. | Lancet | 1974 | https://conductscience.org/library/papers/4140327 | PubMed |
| 5 | 4179349 | Daunorubicin in the treatment of acute myelocytic leukaemia. | Lancet | 1969 | https://conductscience.org/library/papers/4179349 | PubMed |
| 6 | 52000 | Quality and quantity of survival in acute myeloid leukaemia. | Lancet | 1975 | https://conductscience.org/library/papers/52000 | PubMed |
| 7 | 4553226 | Treatment of the acute leukemias. | Semin Hematol | 1972 | https://conductscience.org/library/papers/4553226 | PubMed |
| 8 | 4509106 | Acute myelocytic leukemia in adults. | Cancer | 1972 | https://conductscience.org/library/papers/4509106 | PubMed |
| 9 | 4513355 | Management of adult acute myelogenous leukaemia. | Br Med J | 1973 | https://conductscience.org/library/papers/4513355 | PubMed |
| 10 | 4921703 | Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia. | Br Med J | 1970 | https://conductscience.org/library/papers/4921703 | PubMed |
| 11 | 5279904 | Five-year follow-up of "total therapy" of childhood lymphocytic leukemia. | JAMA | 1971 | https://conductscience.org/library/papers/5279904 | PubMed |
| 12 | 5286084 | Factors effecting remission and survival in adult acute nonlymphocytic leukemia (ANLL). | Medicine (Baltimore) | 1970 | https://conductscience.org/library/papers/5286084 | PubMed |
| 13 | 5284835 | Cytosine arabinoside in acute granulocytic leukemia. | Clin Pharmacol Ther | 1971 | https://conductscience.org/library/papers/5284835 | PubMed |
| 14 | 1057450 | Treatment of acute leukemia in adults. | Cancer | 1975 | https://conductscience.org/library/papers/1057450 | PubMed |
| 15 | 793554 | Developmental therapy in adult acute leukemia. | Arch Intern Med | 1976 | https://conductscience.org/library/papers/793554 | PubMed |
Cited by4
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 37 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 27517413 | Acute myeloid leukaemia-A review of sixty-seven cases. | Ir J Med Sci | 1979 | https://conductscience.org/library/papers/27517413 | PubMed |
| 7347042 | Remission-induction regimens in acute nonlymphocytic leukemia. | West J Med | 1980 | https://conductscience.org/library/papers/7347042 | PubMed |
| 552411 | Cancer chemotherapy. | J R Soc Med | 1979 | https://conductscience.org/library/papers/552411 | PubMed |
| 365212 | Chemotherapy of acute myeloid leukaemia in adults: Medical Research Council. | Br J Cancer | 1979 | https://conductscience.org/library/papers/365212 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/268229
GET https://conductscience.org/api/papers/v1/268229/authors